Welcome to Wopular's coverage of Flaxosmithkline.
Wopular aggregates news headlines from the top newspapers and
news sources. To the right are articles about
Flaxosmithkline that have been featured on main sections
of the site.
Below are topics about Flaxosmithkline. (Click on "all"
to view all articles related to the topic, including articles NOT about
Flaxosmithkline.
U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks.